Lapatinib Plus Caelyx in Patients With Advanced Metastatic Breast Cancer Following Failure of Trastuzumab Therapy
Clinical trial NCT00903656 · TERMINATED
Trial details
- NCT number
- NCT00903656
- Sponsor
- Arbeitsgemeinschaft medikamentoese Tumortherapie
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-05-01
- Primary completion
- 2012-05-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.